Autoantibody-targeting therapies for autoimmune diseases
| Date | Round | Amount |
|---|---|---|
| Jul 2025 | Series B Japanese biotech Link Therapeutics raised a JPY 850m Series B (Itochu Technology Ventures, Kyoto University Innovation Capital, MUFG Medical Fund, SMBC Venture Capital, Kobe University Capital). | $5.5M |